Protalix Biotherapeutics Inc (PLX)

Currency in USD
1.605
+0.025(+1.56%)
Real-time Data·

PLX Earnings

Latest Release
May 09, 2025
EPS / Forecast
-0.05 / 0.03
Revenue / Forecast
10.11M / 21.60M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/0.11--/23.1M----Free Sign Up
03/2025-0.05/0.0310.11M/21.6M-266.67%-53.19%Free Sign Up
12/20240.1/0.118.22M/20.21M0%-9.85%Free Sign Up
09/20240.03/0.0617.96M/16.26M-50%+10.46%Free Sign Up
06/2024-0.03/0.0213.47M/12.5M-250%+7.76%Free Sign Up
03/2024-0.06/-0.063.75M/3.75M0%0%Free Sign Up
12/2023-0.03/-0.0310.47M/10.47M0%0%Free Sign Up
09/2023-0.04/-0.0410.34M/10M0%+3.4%Free Sign Up
06/2023-0.16/-0.0424.84M/10.22M-300%+143.05%Free Sign Up
03/2023-0.05/-0.059.59M/9.59M0%0%Free Sign Up

All numbers in USD

Protalix Biotherapeutics Inc Earnings Call Summary for Q1/2025

  • Protalix reported Q1 2025 net loss of $3.6M, EPS of -$0.05, missing $0.03 forecast; revenue at $10.1M vs $21.6M expected
  • Stock plunged 21.8% in premarket trading following earnings miss; P/E ratio at 72.1x suggests premium valuation
  • Revenue from goods sales up 170% YoY; company plans Phase II trial for gout treatment in late 2025
  • CEO remains optimistic despite financial miss; potential $75M in regulatory milestones with partner Chiesi
  • Analysts maintain $14-15 price targets despite recent pullback; company faces risks of continued underperformance
Last Updated: 09/05/2025, 14:14
Read Full Transcript

FAQ

What Is Protalix's Earnings Per Share (TTM)?

The Protalix EPS (TTM) is 0.05.

When Is The Next Protalix Earnings Date?

Protalix will release its next earnings report on 17 Aug 2025.

What Is Protalix’s Revenue Forecasts For Upcoming Quarters?

Protalix’s revenue forecast is 23.10M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.